Latest filing published 27 Nov 2012 for Infinity Pharmaceuticals, INC., €111k.
Insider track record
No signal scores available.
Christopher M. Lindblom: trading record in brief
Christopher M. Lindblom discloses dealings in Infinity Pharmaceuticals, Inc. to SEC (Form 4). Activity is concentrated on a single trading day, 26 November 2012, with 3 filings.
Sales make up the whole of the open-market record (1 sale, €276k). Outside the open market, there are 2 option exercises.
Most recently, on 27 November 2012, the filings show an option exercise worth €111k in Infinity Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Christopher M. Lindblom
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$14.33Common StockSEC:0001181431-12-060719:0
- 3,885 shares@ US$9.80Common StockSEC:0001181431-12-060719:1
- 13,885 shares@ US$25.73Common StockSEC:0001181431-12-060719:2
3 of 3 declarations
